gadodiamide
CAS: 131410-48-5
Ref. 3D-FG39380
25mg | Descatalogado | ||
50mg | Descatalogado | ||
100mg | Descatalogado | ||
250mg | Descatalogado | ||
500mg | Descatalogado |
Información del producto
- 2,5,8,11-Tetraazatridecan-13-oic acid, 5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-, gadolinium complex
- Dv 7572
- Gadodiamide (500 Mg)
- Gadolinium 2-[Bis[2-(Carboxylatomethyl-(Methylcarbamoylmethyl)Amino)Ethyl]Amino]Acetate
- Gadolinium 5,8-Bis(Carboxylatomethyl)-11-[2-(Methylamino)-2-Oxoethyl]-3-Oxo-2,5,8,11-Tetraazatridecan-13-Oate (Non-Preferred Name)
- Gadolinium, [5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-)]-
- Gadolinium, [5,8-bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-(oxo-κO)ethyl]-3-(oxo-κO)-2,5,8,11-tetraazatridecan-13-oato(3-)-κN<sup>5</sup>,κN<sup>8</sup>,κN<sup>11</sup>,κO<sup>13</sup>]-
- Gadolinium-DTPA-BMA
- Gd-DTPA-BMA
- Omniscan
- Ver más sinónimos
- S-041
- [5,8-Bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraaza-tridecan-13-oato(3-)]gadolinium
- [5,8-Bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-(oxo-κO)ethyl]-3-(oxo-κO)-2,5,8,11-tetraazatridecan-13-oato(3-)-κN<sup>5</sup>,κN<sup>8</sup>,κN<sup>11</sup>,κO<sup>13</sup>]gadolinium
- [5,8-Bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-(oxo-κO)ethyl]-3-(oxo-κO)-2,5,8,11-tetraazatridecan-13-oato(3-)-κN5,κN8,κN11,κO13]gadolinium
- Gadolinium, [5,8-bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-(oxo-κO)ethyl]-3-(oxo-κO)-2,5,8,11-tetraazatridecan-13-oato(3-)-κN5,κN8,κN11,κO13]-
Gadodiamide is an MRI contrast agent that is used for the diagnosis of diseases by imaging the excretory organs, brain, and cardiovascular system. Gadodiamide is a stable gadolinium complex with a high relaxivity in human serum. The compound is slowly cleared from the body, following a one-compartment model. Gadodiamide has been shown to have no significant toxicity in animal models and can be used in humans.